Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai Inc (NASDAQ: MRAI) delivers AI-powered Third-Party Administration services for self-funded health plans, combining deep learning with healthcare cost management. This news hub provides investors and benefits professionals with essential updates on the company's operational developments and strategic initiatives.
Access comprehensive coverage of Marpai's financial announcements, technology advancements, and partnership updates. Our curated news collection features press releases detailing cost-containment programs, artificial intelligence implementations, and service expansions within the $22 billion TPA market.
Key updates include earnings reports, leadership changes, predictive analytics breakthroughs, and network expansions. The repository serves as a centralized source for tracking Marpai's progress in reducing employer healthcare costs through machine learning applications and operational optimizations.
Bookmark this page for real-time updates on Marpai's initiatives in healthcare AI and benefits administration. Regularly refreshed content ensures stakeholders maintain current understanding of the company's market position and technological innovations in the evolving TPA sector.
Marpai, Inc. (Nasdaq: MRAI) has successfully closed a public offering of 7,400,000 shares at a price of
Marpai, Inc. (Nasdaq: MRAI) has announced an underwritten public offering of 7,400,000 shares of its common stock priced at
The proceeds will be used primarily for debt repayment related to the acquisition of Maestro Health (at least 35% of the funds) and the remainder for general corporate purposes. The offering is filed under a shelf registration statement with the SEC. ThinkEquity is the sole book-running manager for the offering.
Marpai, Inc. (Nasdaq: MRAI) announced its intention to conduct an underwritten public offering of its common stock, with all shares being sold by the Company. ThinkEquity is acting as the sole book-running manager for this offering. The exact size and terms remain uncertain as the offering is contingent upon market conditions.
The net proceeds from the offering will be used primarily for repaying debt incurred from the acquisition of Maestro Health, with at least 35% allocated for this purpose, while the remainder will cover general corporate uses.
The offering will be registered under an existing SEC Form S-3 shelf registration statement. No sales will occur in jurisdictions where the offering would be unlawful without proper registration or qualification.
Marpai, Inc. (Nasdaq: MRAI) reported a significant 54% increase in revenue for the fourth quarter of 2022, totaling approximately $7.6 million compared to $4.9 million in Q3 2022. This growth is primarily attributed to the acquisition of Maestro Health. For the full year 2022, net revenues reached $24.3 million, up 71% from 2021. However, the company also faced increased operating losses of approximately $8.9 million in Q4 2022 and a full-year net loss of $26.5 million. Financial guidance for 2023 anticipates revenues between $34 million and $35 million.
Marpai, Inc. (Nasdaq: MRAI) is set to host a conference call on March 30, 2023, at 8:30 a.m. ET to discuss its operational and financial highlights for the fourth quarter and full year of 2022. The results will be released after trading on March 29, 2023. The company specializes in AI-powered health plan services aimed at self-funded employer health plans, competing in a $22 billion Third Party Administrator sector. Investors can join via phone or through a webcast available on their official site.
FAQ
What is the current stock price of Marpai (MRAI)?
What is the market cap of Marpai (MRAI)?
